AssociatiNG Bevacizumab bEmarituzumab for GynecoLogIcal CAncer

NCT07146919 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Molecule not available from the laboratory

Conditions

Endometrial Carcinoma
Ovarian Cancer
Cervix Cancer

Interventions

DRUG: Bemarituzumab
DRUG: Bevacizumab

Sponsor

Centre Leon Berard